Epidemiological shifts in bronchiolitis patterns and impact of the COVID-19: A two-season comparative study.
COVID-19 pandemic
bronchiolitis
respiratory syncytial virus
respiratory viruses
rhinovirus
Journal
Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590
Informations de publication
Date de publication:
14 Feb 2024
14 Feb 2024
Historique:
revised:
25
01
2024
received:
22
10
2023
accepted:
31
01
2024
medline:
14
2
2024
pubmed:
14
2
2024
entrez:
14
2
2024
Statut:
aheadofprint
Résumé
Bronchiolitis is a common lower respiratory tract infection (LRTI) affecting infants and young children. Respiratory syncytial virus (RSV) has historically been the primary causative agent, but other viruses also contribute to the LRTI epidemiology. Recent changes in epidemiology and clinical patterns due to the coronavirus disease 2019 (COVID-19) pandemic have raised concerns. This study aims to analyze the impact of the pandemic on bronchiolitis epidemiology and severity. Two consecutive bronchiolitis seasons (October 2021 to March 2022 and October 2022 to March 2023) were compared. Data on viral agents, hospitalization duration, clinical severity, and respiratory support requirements were collected from pediatric patients at San Marco Hospital, University of Catania. In the 2021-2022 season, RSV was the predominant virus (40%), followed by other viruses, with mild clinical outcomes. In the 2022-2023 season, RSV remained prevalent (58.7%), but other viruses, including rhinovirus (RV) and influenza, showed a significant increase (p < .05) in bronchiolitis cases and severity. Notably, RSV-related bronchiolitis did not exhibit greater severity compared to non-RSV cases in the 2022-2023 season, contrary to the previous year. The COVID-19 pandemic appears to have shifted the epidemiological landscape of bronchiolitis, with a peak incidence in November instead of January/February. Non-RSV viruses (RV, influenza A and B, as well as metapneumovirus) have gained prominence, possibly due to viral competition and reduced pandemic-related restrictions. Traditionally, RSV has been the primary pathogen responsible for most bronchiolitis cases. Nonetheless, the findings of this study indicate a shifting landscape in bronchiolitis etiology, with RSV gradually diminishing in its role. Contrary to the previous year, RSV-related bronchiolitis did not exhibit greater severity compared to non-RSV cases in the 2022-2023 season.
Sections du résumé
BACKGROUND
BACKGROUND
Bronchiolitis is a common lower respiratory tract infection (LRTI) affecting infants and young children. Respiratory syncytial virus (RSV) has historically been the primary causative agent, but other viruses also contribute to the LRTI epidemiology. Recent changes in epidemiology and clinical patterns due to the coronavirus disease 2019 (COVID-19) pandemic have raised concerns. This study aims to analyze the impact of the pandemic on bronchiolitis epidemiology and severity.
METHODS
METHODS
Two consecutive bronchiolitis seasons (October 2021 to March 2022 and October 2022 to March 2023) were compared. Data on viral agents, hospitalization duration, clinical severity, and respiratory support requirements were collected from pediatric patients at San Marco Hospital, University of Catania.
RESULTS
RESULTS
In the 2021-2022 season, RSV was the predominant virus (40%), followed by other viruses, with mild clinical outcomes. In the 2022-2023 season, RSV remained prevalent (58.7%), but other viruses, including rhinovirus (RV) and influenza, showed a significant increase (p < .05) in bronchiolitis cases and severity. Notably, RSV-related bronchiolitis did not exhibit greater severity compared to non-RSV cases in the 2022-2023 season, contrary to the previous year.
CONCLUSION
CONCLUSIONS
The COVID-19 pandemic appears to have shifted the epidemiological landscape of bronchiolitis, with a peak incidence in November instead of January/February. Non-RSV viruses (RV, influenza A and B, as well as metapneumovirus) have gained prominence, possibly due to viral competition and reduced pandemic-related restrictions. Traditionally, RSV has been the primary pathogen responsible for most bronchiolitis cases. Nonetheless, the findings of this study indicate a shifting landscape in bronchiolitis etiology, with RSV gradually diminishing in its role. Contrary to the previous year, RSV-related bronchiolitis did not exhibit greater severity compared to non-RSV cases in the 2022-2023 season.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Bando di Ricerca finalizzata-2019. MIUR-GR-2019-12371550
Informations de copyright
© 2024 Wiley Periodicals LLC.
Références
Manti S, Staiano A, Orfeo L, et al. UPDATE-2022 Italian guidelines on the management of bronchiolitis in infants. Ital J Pediatr. 2023;49(1):19.
Gastaldi A, Donà D, Barbieri E, Giaquinto C, Bont LJ, Baraldi E. COVID-19 lesson for respiratory syncytial virus (RSV): hygiene works. Children. 2021;8(12):1144.
Li Y, Wang X, Blau DM, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022;399(10340):2047-2064.
Mazur NI, Martinón-Torres F, Baraldi E, et al. Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics. Lancet Respir Med. 2015;3(11):888-900.
Nenna R, Matera L, Licari A, et al. An Italian multicenter study on the epidemiology of respiratory syncytial virus during SARS-CoV-2 pandemic in hospitalized children. Front Pediatr. 2022;10:930281.
Di Mattia G, Nenna R, Mancino E, et al. During the COVID-19 pandemic where has respiratory syncytial virus gone? Pediatr Pulmonol. 2021;56(10):3106-3109.
Presti S, Lo Bianco M, Mollica F, Papale M, Parisi GF, Leonardi S. Post-lockdown respiratory virus epidemiology: a monocentric observational study. Pediatr Respir J. 2022;01:31-37.
Presti S, Manti S, Gambilonghi F, Parisi GF, Papale M, Leonardi S. Comparative analysis of pediatric hospitalizations during two consecutive influenza and respiratory virus seasons post-pandemic. Viruses. 2023;15(9):1825.
Nayani K, Naeem R, Munir O, et al. The clinical respiratory score predicts paediatric critical care disposition in children with respiratory distress presenting to the emergency department. BMC Pediatr. 2018;18:339.
Manti S, Licari A. How to obtain informed consent for research. Breathe. 2018;14(2):145-152.
World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-2194.
Hussain F, Delgado Thompson M, Vick D, West J, Edwards M. Clinical severity of RSV bronchiolitis. Health Sci Rep. 2022;5(2):e543.
Curatola A, Lazzareschi I, Bersani G, Covino M, Gatto A, Chiaretti A. Impact of COVID-19 outbreak in acute bronchiolitis: lesson from a tertiary Italian emergency department. Pediatr Pulmonol. 2021;56(8):2484-2488.
Robinson E, Smyth RL. Preventing respiratory syncytial virus bronchiolitis in infants. BMJ. 2023;381:p1023.
Zhang A, Surette MD, Schwartz KL, et al. The collapse of infectious disease diagnoses commonly due to communicable respiratory pathogens during the coronavirus disease 2019 pandemic: a time series and hierarchical clustering analysis. Open Forum Infect Dis. 2022;9(7):ofac205.
Ghirardo S, Ullmann N, Ciofi Degli Atti ML, Raponi M, Cutrera R. Delayed season's onset and reduction of incidence of bronchiolitis during COVID-19 pandemic. Pediatr Pulmonol. 2021;56(8):2780-2781.
Chiapinotto S, Sarria EE, Mocelin HT, Lima JAB, Mattiello R, Fischer GB. Impact of non-pharmacological initiatives for COVID-19 on hospital admissions due to pediatric acute respiratory illnesses. Paediatr Respir Rev. 2021;39:3-8.
Tempia S, Walaza S, Bhiman JN, et al. Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020. Euro Surveill. 2021;26(29):2001600.
Camporesi A, Morello R, Ferro V, et al. Epidemiology, microbiology and severity of bronchiolitis in the first post-lockdown cold season in three different geographical areas in Italy: a prospective, observational study. Children. 2022;9(4):491.
van Summeren J, Meijer A, Aspelund G, et al. VRS study group in Lyon, de Lusignan S, Teirlinck AC, et al. low levels of respiratory syncytial virus activity in Europe during the 2020/21 season: what can we expect in the coming summer and autumn/winter? Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2021;26(29):2100639.
Chuang Y-C, Lin K-P, Wang L-A, Yeh T-K, Liu P-Y. The impact of the COVID-19 pandemic on respiratory syncytial virus infection: a narrative review. Infect Drug Resist. 2023;16:661-675.
Rao S, Armistead I, Messacar K, et al. Shifting epidemiology and severity of respiratory syncytial virus in children during the COVID-19 pandemic. JAMA Pediatr. 2023;177(7):730-732.
Piret J, Boivin G. Viral interference between respiratory viruses. Emerging Infect Dis. 2022;28(2):273-281.
Fourgeaud J, Toubiana J, Chappuy H, et al. Impact of public health measures on the post-COVID-19 respiratory syncytial virus epidemics in France. Eur J Clin Microbiol Infect Dis. 2021;40(11):2389-2395.
Chong S-L, Soo JSL, Allen JC, et al. Impact of COVID-19 on pediatric emergencies and hospitalizations in Singapore. BMC Pediatr. 2020;20(1):562.
Guitart C, Bobillo-Perez S, Alejandre C, et al. Bronchiolitis, epidemiological changes during the SARS-CoV-2 pandemic. BMC Infect Dis. 2022;22(1):84.
Faraguna MC, Lepri I, Clavenna A, et al. The bronchiolitis epidemic in 2021-2022 during the SARS-CoV-2 pandemic: experience of a third level centre in Northern Italy. Ital J Pediatr. 2023;49(1):26.
Hamid S, Winn A, Parikh R, et al. Seasonality of respiratory syncytial virus-United States, 2017-2023. MMWR Morb Mortal Wkly Rep. 2023;72(14):355-361.
Reina J, Arcay RM, Busquets M, Machado H. Impact of hygienic and social distancing measures against SARS-CoV-2 on respiratory infections caused by other viruses. Rev Esp Quimioter. 2021;34(4):365-370.
Van Brusselen D, De Troeyer K, Ter Haar E, et al. Bronchiolitis in COVID-19 times: a nearly absent disease? Eur J Pediatr. 2021;180(6):1969-1973.
Daniels D, Wang D, Suryadevara M, et al. Epidemiology of RSV bronchiolitis among young children in central New York before and after the onset of the COVID-19 pandemic. Pediatr Infect Dis J. 2023;42(12):1056-1062. doi:10.1097/INF.0000000000004101
Lazzerini M, Barbi E, Apicella A, Marchetti F, Cardinale F, Trobia G. Delayed access or provision of care in Italy resulting from fear of COVID-19. Lancet Child Adolesc Health. 2020;4(5):e10-e11.
Cohen R, Ashman M, Taha M-K, et al. Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap? Infect Dis Now. 2021;51(5):418-423.